Preclinical imaging is a medical process of viewing live animals for research purposes, such as new medical procedures and drug development. The technological development of in vivo images offers the possibility of studying the disease at the molecular level quantitatively. In vivo imaging serves as a bridge between in vitro clinical exploratory research and in vivo clinical research that facilitates the direct and rapid transfer of preclinical studies in animal models to clinical research in humans. Imaging modalities are crucial for researchers to observe changes in the tissue, organ, molecule or cell in response to physiological or environmental changes.
Underlying Causes The growth for Asia-Pacific Preclinical In-vivo Imaging Market is driven due to factors like increasing prevalence of chronic diseases like diabetes, immunological, cardiovascular, and neurodegenerative diseases, rising demand for non-invasive imaging techniques, growing awareness about various imaging techniques among people, and increasing healthcare expenditure. In addition, technological advancements in molecular imaging modalities, growing acceptance of preclinical imaging as a legitimate drug development tool, increasing investments for R&D activities by government and private organizations, introduction of novel technologies such as electronics, detectors, reconstruction algorithms and improving healthcare facilities are expected to drive the market growth. However, high cost of equipment, stringent regulatory policies, and limited number of application of each modality is expected to restrain the growth rate for Asia-Pacific Preclinical In-vivo Imaging Market during the forecast period.
Geographic Segmentation: Based on geography the Asia-Pacific Preclinical In-vivo Imaging Market has been primarily divided into China, India, South Korea, Japan and Australia. Asia-Pacific regions like India and China are rapidly growing due to rising aging population, increasing government funding for development of pharmaceutical industry, and growing R&D activities by major pharmaceutical companies are expected to contribute high growth rate for Asia-Pacific Preclinical In-vivo Imaging Market during the forecast period.
Key Players: Leading companies for Asia-Pacific Preclinical In-vivo Imaging Market are Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc.
About MarketDataForecast™ Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Contact Information: Name: Mr. Abhishek Shukla Email: email@example.com Organization: MarketDataForecast™ Address: 2nd Floor, Above ICICI Bank Filmnagar Branch, B 44, Rd Number 3, Journalist Colony, Hyderabad, Telangana 500033. Phone: +1-888-702-9626